Galapagos price target lowered to EUR 29 from EUR 34 at JPMorgan
PremiumThe FlyGalapagos price target lowered to EUR 29 from EUR 34 at JPMorgan
18d ago
Excellos selected to support Galapagos’ CAR-T cell therapy clinical study
Premium
The Fly
Excellos selected to support Galapagos’ CAR-T cell therapy clinical study
1M ago
Galapagos initiated with a Market Perform at Leerink
Premium
The Fly
Galapagos initiated with a Market Perform at Leerink
2M ago
GLPG Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsGLPG Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
Galapagos Unveils Promising Cancer Therapy Data
Premium
Company Announcements
Galapagos Unveils Promising Cancer Therapy Data
5M ago
Galapagos presents new data from ATALANTA-1 study
Premium
The Fly
Galapagos presents new data from ATALANTA-1 study
5M ago
Galapagos NV Unveils Employee Subscription Plans
PremiumCompany AnnouncementsGalapagos NV Unveils Employee Subscription Plans
6M ago
Galapagos creates new subscription rights plans
Premium
The Fly
Galapagos creates new subscription rights plans
6M ago
Galapagos NV Expands U.S. CAR-T Therapy Production
Premium
Company Announcements
Galapagos NV Expands U.S. CAR-T Therapy Production
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100